Plasmidsaurus, the leading Sequencing as a Service company, has announced two transformative evolutions of its RNA-Seq ecosystem: the launch of a high-capacity RNA sequencing hub in Cologne, Germany, and a global partnership with Genovis to release SEQguard™ Dino Preserve, an RNA preservation solution that enables ambient shipping of purified RNA samples for sequencing.
The Plasmidsaurus mission is to accelerate science with the best sequencing. With these updates, they are continuing to dismantle the barriers in transcriptomics to bring affordable, accessible sequencing to their community of innovators worldwide. While these milestones represent independent achievements, they converge on a single goal: a modernized, "frictionless" workflow that ensures science gets the best sequencing it deserves.
Expanding the European Footprint: From the UK to Cologne
The addition of RNA-seq services into the Plasmidsaurus Cologne facility marks a significant advancement of the Plasmidsaurus European infrastructure. Building on the success of the company's established presence in the United Kingdom, this new capability brings lightning-fast RNA-Seq directly into the heart of the European Union.
This expansion is about more than just proximity; it is a commitment to a sustainable, localized service model that delivers fast, reliable answers to the questions driving research. By processing RNA samples directly within the EU, Plasmidsaurus drastically reduces transit distances and cuts carbon emissions, allowing researchers to bypass the logistical hurdles of international borders. Now, European RNA researchers can utilize the ever-expanding network of Plasmidsaurus dropboxes and an optimized regional pipeline to provide a 3-day turnaround time, moving from sample to insight faster than ever.
The Shipping Revolution: Breaking the Ice with Genovis
In a separate milestone, Plasmidsaurus announced the launch of SEQguard™ Dino Preserve, an RNA preservation solution developed through a strategic partnership with Genovis AB. SEQguard™ Dino Preserve has been tested and optimized for seamless integration into Plasmidsaurus RNA-Seq workflows, enabling researchers to ship purified RNA samples at ambient temperatures without compromising the high sequencing quality they have come to expect from Plasmidsaurus.
For decades, high costs, bulky packaging, and environmental impact of dry ice shipments required to safely ship precious purified RNA-seq samples, have been a mandatory burden for
researchers. SEQguard™ Dino Preserve eliminates this requirement entirely in a single, simple step. The solution remains active across a wide temperature range and tolerates freeze-thaw cycles, enabling reliable ambient shipping year-round, and ensuring stability from the bench to the Plasmidsaurus dropbox without the hassle of dry ice.
SEQguard™ Dino Preserve key specifications:
Accelerating Discovery
“By partnering with Genovis to bring SEQguard™ Dino Preserve into the Plasmidsaurus ecosystem, we’re making high-quality RNA-seq as simple and reliable as dropping off a tube at a local dropbox. Together, we eliminate the logistical headache so customers can focus on their science, not shipping, unlocking unprecedented simplicity for ultrafast, high-quality gene expression data,” said Mark Budde, CEO and co-founder of Plasmidsaurus.
About Plasmidsaurus
Plasmidsaurus is on a mission to accelerate science with the best sequencing. The company's sequencing services, spanning whole plasmids, RNA-seq, amplicons, whole genomes, and microbiomes, are used daily by thousands of innovators, including Nobel Prize winners, dynamic biotech startups, pharmaceutical companies, research labs, and DIY biohackers. Plasmidsaurus's global network of labs operates day and night to enable world-changing discoveries.
To learn more about Plasmidsaurus, visit: plasmidsaurus.com
About Genovis
Headquartered in Kävlinge, Sweden, Genovis offers customers in the biopharmaceutical and research industries tools that facilitate and save time in the development of new treatment methods and diagnostics. Genovis enzyme products, known as SmartEnzymes, are used by scientists all over the world and the innovative product formats facilitate development and quality control of biological drugs. The Group consists of Genovis AB and the wholly owned subsidiary Genovis Inc. (US) and SEQURNA AB. Genovis shares are listed on Nasdaq First North Growth Market and DNB Carnegie Investment Bank AB is the Company’s Certified Adviser.